Related Experiment Videos
Are the insulin-like growth factors relevant to cancer?
1MMC 806, 420 Delaware Street SE, University of Minnesota Cancer Center, Minneapolis, MN 55455, USA. yeexx006@umn.edu
Abstract:
Recognition of molecular pathways relevant to cancer biology have led to advances in prevention and treatment. Numerous laboratory and clinical investigations have implicated the insulin-like growth factors (IGFs) in tumourigenesis. In this review, the evidence for the involvement of IGFs in cancer is discussed. While these data are persuasive, it is clear that additional methods to regulate IGF action in cancer patients are needed to substantiate the role of this growth factor family in cancer biology.
Insights
Insulin-like growth factors (IGFs) are implicated in cancer development. Further research is needed to explore therapeutic strategies targeting IGFs for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Molecular pathway discovery drives cancer prevention and treatment advances.
- Insulin-like growth factors (IGFs) are increasingly implicated in tumorigenesis through laboratory and clinical studies.
Purpose of the Study:
- To review the evidence linking IGFs to cancer biology.
- To identify the need for novel therapeutic strategies targeting IGFs in cancer patients.
Main Methods:
- Literature review of laboratory and clinical investigations.
- Synthesis of evidence on IGF involvement in cancer.
Main Results:
- Persuasive evidence supports the role of IGFs in cancer development.
- Current data highlight the necessity for improved methods to regulate IGF action.
Conclusions:
- IGFs play a significant role in cancer biology.
- Targeting IGF pathways presents a potential therapeutic avenue for cancer treatment, requiring further investigation.